Levine Cancer Institute University — Charlotte, North Carolina

Levine Cancer Institute University is a clinical research site located in Charlotte, North Carolina, United States 28262.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Levine Cancer Institute University has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Urothelial Carcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Amgen.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Levine Cancer Institute University?

Levine Cancer Institute University has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Levine Cancer Institute University conducted?

Levine Cancer Institute University has 2 clinical trials on record, with 2 currently active. Their work covers Urothelial Carcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma.

Is Levine Cancer Institute University accredited by Crixeo Health?

Levine Cancer Institute University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Levine Cancer Institute University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.